AdvaMed Chair: Another Device Tax Moratorium More Likely Than A Full Repeal
As the top medtech lobby groups continue to push for a permanent repeal of the medical device excise tax, one of their top lobbyists and medtech executives says it’s far more likely they will see another multiyear moratorium considering the political reality.
You may also be interested in...
After an eleventh-hour win last year that saw Congress repeal the medical device excise tax, AdvaMed is going more global. CEO Scott Whitaker sat down with Medtech Insight for a lengthy chat about what the lobby group will focus on in 2020, including reimbursement challenges, the upcoming medical device user-fee negotiations, and negotiations with governments that are key to the industry ecosystem.
US lawmakers have agreed on a bipartisan budget to prevent a government shutdown that includes repealing the medical device tax. If all goes according to plan, the bill -- which was approved by the House on 17 December and is now headed to the Senate -- is expected to be on the president’s desk for signing by the end of the week.
Industry trade groups spend millions of dollars and walk thousands of steps in the halls of the US Congress each year to persuade legislators and their staff to support votes on device-tax repeal, Medicare payment reform, and other issues. Using lobbying reports downloaded by a public interest group, Medtech Insight has analyzed what industry spent and paid out to hire legislative experts to lobby Congress in the first half of 2019, and which topics they lobbied for the most.